The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

  • Post date May 13, 2022 — 20:12 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000999 002727 002821 300015 300171 300244 300347 300358 300363 300595 300759 300760 Aier Eye Hospital Group Asymchem Laboratories (Tianjin) Beijing Tongrentang Bloomage Biotechnology Corporation Limited China Resources Sanjiu Medical & Pharmaceutical Dashenlin Pharmaceutical Group Dian Diagnostics Group Fortune Ng Fung Food Guangzhou Kingmed Diagnostics Group Hangzhou Tigermed Consulting Joinn Laboratories LBX Pharmacy Chain Joint Stock Company Ovctek China Pharmaron Beijing Porton Pharma Solutions Shanghai Medicilon Shanghai Tofflon Science And Technology Shenzhen Mindray Bio-Medical Electronics Truking Technology Limited Wuxi Apptec Yifeng Pharmacy Chain Yixintang Pharmaceutical Group Zhangzhou Pientzehuang Pharmaceutical Zhejiang Jiuzhou Pharmaceutical Annual, Special Corporate Meeting Annual Report Pharmaceutical Retail Epidemic Traditional Chinese Medicine, Tcm Biology

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data